Nervenarzt. 2004 May 19
Ganzinger U, Badelt C, Vass K, Strasser-Fuchs S, Fazekas F, Berger T, Dahlke F.
Schering Wien GmbH, Wien, Osterreich.
A retrospective, cross-sectional study was performed to evaluate direct and indirect costs related to multiple sclerosis (MS) in Austria in a representative cohort of patients ( n=895) with typical symptoms.
Demographic, socioeconomic, and disease-related data including degree of disability and health-related quality of life as well as consumption of medical and nonmedical resources were recorded and mean total costs per patient and year were calculated (based on 1999 figures).
Total direct costs borne by public sources were 15,684 <euro> per MS patient per year.
Overall societal costs increased disproportionately with the progression of the disease, from 12,990 <euro> per year in patients with mild disability to 69,554 <euro> per year in patients with severe disability.
Increasing disability was reflected by substantial deterioration of health status-related quality of life.
Direct costs of MS in Austria are similar to those in other countries.